EMA launches Regulatory Science research needs initiative in online event

20 January 2022
Share this article

On Tuesday January 18th, the European Medicines Agency (EMA) hosted the Regulatory Science Research Needs (RSRN) launch event. The online event was organized to inform the public and stakeholders, such as researchers and research funders, on the RSRN initiative.

The Regulatory Science Research Needs list is a periodically updated list that provides an overview of approximately one hundred topics identified by EMA that require additional research to address knowledge gaps in regulatory science. Research in these areas can support medicine development and evaluation, ultimately helping patients in the European Union (EU) to access innovative medicines that address their unmet needs.

The inspiring launch event was attended by several Regulatory Science Network Netherlands’ (RSNN) representatives. “RSNN is fully prepared to be engaged in contributing to the EMA RSRN agenda and strategy.” said Bert Leufkens (Chair of RSNN).

RSNN provides a neutral platform to discuss implementation challenges of regulatory science innovations for its stakeholders through e.g., its regular small scale topical expert meetings. RSNN welcomes the RSRN initiative and is looking forward to helping address the needs identified by EMA.

For more information on the RSRN, please visit the RSRN webpage on the EMA site.